The Fiscal Year 2008 (FY08) Defense Appropriations Act provides $10 million to the Department of Defense Ovarian Cancer Research Program (OCRP) to support high-impact, innovative research to eliminate ovarian cancer. This program is administered by the U.S. Army Medical Research and Materiel Command through the Office of the Congressionally Directed Medical Research Programs (CDMRP). Detailed descriptions of each of the funding mechanisms, evaluation criteria, and submission requirements can be found at the link above.